Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis
Clinical trial NCT04818671 · COMPLETED
Trial details
- NCT number
- NCT04818671
- Sponsor
- argenx
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-26
- Primary completion
- 2024-12-31
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.